altimmune glp 1 Altimmune's GLP-1 Drug Reduces Heavy Drinking in Alcohol-Use Disorder Trial. Altimmune's pemvidutide achieved a statistically significant reduction in heavy drinking days compared to a placebo in a Phase 2 trial. This peptide Altimmune stock sinks on mixed
Pay in 4 interest-free payments of $5.66 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12















/prd-cl/product-medias/87518384-852b-43a0-8e22-ba56f5e59fc6/MK5AO8D5SK/MK5AO8D5SK-1/1772679864496-MK5AO8D5SK-1-1.png)












